Thomas Hallam, outgoing Palisade Bio CEO
October 11, 2022 10:17 AM EDT
People

An­oth­er biotech CEO de­parts, leav­ing be­hind few em­ploy­ees for PhI­II

Kyle LaHucik

Senior Reporter

A month af­ter lay­ing off 20% of its em­ploy­ees, Pal­isade Bio’s CEO is al­so out the door. Thomas Hal­lam hit the ex­it on Mon­day and …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

FDA vac­cine chief Pe­ter Marks pledges to stay as long as he's wel­come

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times